verapamil hydrochloride , the prototype calcium-channel blocking agent for arrhythmias , is effective for pva , but only 10-20 % of an orally administered dose reaches systemic circulation because of the first-pass effect .
C0700468
verapamil hydrochloride
C0002963
pva